|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4723027A
(en)
|
1982-11-22 |
1988-02-02 |
E. I. Du Pont De Nemours And Company |
Preparation of optically active alpha-hydroxynitriles
|
|
ZA837994B
(en)
|
1982-11-22 |
1984-06-27 |
Shell Oil Co |
Process for the preparation of optically-active cyanomethyl esters
|
|
JPS60100516A
(ja)
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
|
US5364620A
(en)
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
|
CA1256638A
(en)
|
1984-07-06 |
1989-06-27 |
Motoaki Tanaka |
Polymer and its production
|
|
JP2551756B2
(ja)
|
1985-05-07 |
1996-11-06 |
武田薬品工業株式会社 |
ポリオキシカルボン酸エステルおよびその製造法
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
US4741897A
(en)
|
1986-07-08 |
1988-05-03 |
Baxter Travenol |
Thyroxine analogs and reagents for thyroid hormone assays
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
ATE195716T1
(de)
|
1992-04-22 |
2000-09-15 |
Ligand Pharm Inc |
Retinoid-x rezeptor selektive verbindungen
|
|
DE4320444A1
(de)
|
1993-06-21 |
1994-12-22 |
Agfa Gevaert Ag |
Farbfotografisches Aufzeichnungsmaterial
|
|
US6236946B1
(en)
|
1995-12-13 |
2001-05-22 |
Thomas S. Scanlan |
Nuclear receptor ligands and ligand binding domains
|
|
JPH09301917A
(ja)
|
1996-05-08 |
1997-11-25 |
Koichi Shudo |
甲状腺ホルモン作用性化合物
|
|
WO1998007435A1
(en)
|
1996-08-20 |
1998-02-26 |
The Regents Of The University Of California |
Eye treatments using synthetic thyroid hormone compositions
|
|
US5883294A
(en)
|
1997-06-18 |
1999-03-16 |
The Regeants Of The University Of California |
Selective thyroid hormone analogs
|
|
GB9713739D0
(en)
|
1997-06-27 |
1997-09-03 |
Karobio Ab |
Thyroid receptor ligands
|
|
CA2335551C
(en)
|
1998-06-30 |
2009-03-03 |
The Regents Of The University Of California |
Thyroid hormone analogues and methods for their preparation
|
|
GB9828442D0
(en)
|
1998-12-24 |
1999-02-17 |
Karobio Ab |
Novel thyroid receptor ligands and method II
|
|
CA2375674A1
(en)
*
|
1999-06-01 |
2000-12-07 |
Robert Scott Youngquist |
Biaryl compounds
|
|
ES2240017T3
(es)
|
1999-09-30 |
2005-10-16 |
Pfizer Products Inc. |
Derivados de 6-azauracilo como ligandos de receptores tiroideos.
|
|
US6787652B1
(en)
|
1999-09-30 |
2004-09-07 |
Pfizer, Inc. |
6-Azauracil derivatives as thyroid receptor ligands
|
|
US6436990B1
(en)
|
1999-10-27 |
2002-08-20 |
Nobex Corporation |
6-methoxy-2-naphthylacetic acid prodrugs
|
|
EP1127882A1
(en)
|
2000-01-25 |
2001-08-29 |
Pfizer Products Inc. |
Tetrazole compounds as thyroid receptor ligands
|
|
ES2242723T3
(es)
|
2000-02-17 |
2005-11-16 |
Bristol-Myers Squibb Company |
Ligandos derivados de anilina para el receptor de la tiroides .
|
|
EP1148054B1
(en)
|
2000-04-21 |
2005-11-23 |
Pfizer Products Inc. |
Thyroid receptor ligands
|
|
DE10024939A1
(de)
|
2000-05-19 |
2001-11-29 |
Bayer Ag |
Neue Diphenylmethanderivate für Arzneimittel
|
|
US6429223B1
(en)
|
2000-06-23 |
2002-08-06 |
Medinox, Inc. |
Modified forms of pharmacologically active agents and uses therefor
|
|
US7067532B2
(en)
|
2000-11-02 |
2006-06-27 |
Astrazeneca |
Substituted quinolines as antitumor agents
|
|
US6777442B2
(en)
|
2001-03-12 |
2004-08-17 |
Bayer Aktiengesellschaft |
Diphenyl derivatives
|
|
EP1383729A4
(en)
|
2001-04-05 |
2006-04-19 |
Smithkline Beecham Corp |
DEFORMYLASE PEPTIDE INHIBITORS
|
|
US7560433B2
(en)
|
2001-12-21 |
2009-07-14 |
Biotempt B.V. |
Treatment of multiple sclerosis (MS)
|
|
AU2003220558A1
(en)
|
2002-03-27 |
2004-06-03 |
Smithkline Beecham Corporation |
Amide compounds and methods of using the same
|
|
US7302347B2
(en)
|
2002-12-10 |
2007-11-27 |
The Regents Of The University Of California |
Method for creating specific, high affinity nuclear receptor pharmaceuticals
|
|
US7321065B2
(en)
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
|
US8071134B2
(en)
|
2003-09-15 |
2011-12-06 |
Ordway Research Institute, Inc. |
Thyroid hormone analogs and methods of use
|
|
CN1882327A
(zh)
|
2003-11-19 |
2006-12-20 |
症变治疗公司 |
含磷的新的拟甲状腺素药
|
|
WO2006012015A2
(en)
|
2004-06-29 |
2006-02-02 |
Oregon Health And Science University |
Methods and compositions for nerve regeneration
|
|
CN101102758B
(zh)
|
2004-09-15 |
2011-11-16 |
奥德威研究院 |
促进血管新生的甲状腺激素类似物
|
|
TWI385164B
(zh)
|
2005-02-17 |
2013-02-11 |
Astellas Pharma Inc |
Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (II)
|
|
WO2006128056A2
(en)
|
2005-05-26 |
2006-11-30 |
Metabasis Therapeutics, Inc. |
Novel phosphinic acid-containing thyromimetics
|
|
CN101180097A
(zh)
|
2005-05-26 |
2008-05-14 |
症变治疗公司 |
新型含次膦酸的拟甲状腺素药
|
|
EP1891080A2
(en)
|
2005-05-26 |
2008-02-27 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
|
MX2007014502A
(es)
|
2005-05-26 |
2008-02-07 |
Metabasis Therapeutics Inc |
Tiromimeticos para el tratamiento de enfermedades del higado graso.
|
|
US9220788B2
(en)
|
2009-06-17 |
2015-12-29 |
Nanopharmaceuticals Llc |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
|
|
DE102005056930A1
(de)
*
|
2005-11-29 |
2007-05-31 |
Infineon Technologies Ag |
Halbleiter-Bauelement-Test-Verfahren, Halbleiter-Bauelement-Testgerät, sowie zwischen ein Testgerät und ein zu testendes Halbleiter-Bauelement geschaltete Einrichtung
|
|
GB0606212D0
(en)
|
2006-03-28 |
2006-05-10 |
Karobio Ab |
Pharmaceutical compositions
|
|
GB0608724D0
(en)
|
2006-05-03 |
2006-06-14 |
Karobio Ab |
Novel Pharmaceutical Compositions
|
|
WO2007132475A1
(en)
|
2006-05-15 |
2007-11-22 |
Cadila Healthcare Limited |
Selective tr-beta 1 agonist
|
|
CN101600450A
(zh)
|
2006-10-20 |
2009-12-09 |
比奥根艾迪克Ma公司 |
利用可溶性淋巴毒素β受体的脱髓鞘病的治疗
|
|
WO2008052354A1
(en)
|
2006-11-03 |
2008-05-08 |
University Of Saskatchewan |
Method of treating demyelination diseases
|
|
CN101547898B
(zh)
|
2006-12-10 |
2014-09-24 |
于崇曦 |
β-内酰胺类抗生素的透皮给药系统
|
|
ES2500053T3
(es)
|
2007-03-09 |
2014-09-29 |
Chelsea Therapeutics, Inc. |
Composición farmacéutica que comprende droxidopa para el tratamiento de la fibromialgia
|
|
FI20075245A0
(fi)
|
2007-04-11 |
2007-04-11 |
Markku Ahotupa |
Menetelmä oksidatiivisen metabolian arvioimiseksi
|
|
US8138201B2
(en)
|
2007-07-11 |
2012-03-20 |
Medicinova, Inc. |
Treatment of progressive neurodegenerative disease with ibudilast
|
|
WO2009097995A1
(de)
|
2008-02-07 |
2009-08-13 |
Sanofi-Aventis |
Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2278999B1
(en)
|
2008-04-21 |
2025-01-29 |
Dompé farmaceutici S.p.A. |
Auris formulations for treating otic diseases and conditions
|
|
EP2136317B1
(en)
*
|
2008-06-19 |
2013-09-04 |
Samsung Electronics Co., Ltd. |
Method and apparatus for recognizing characters
|
|
US8475804B2
(en)
|
2009-02-20 |
2013-07-02 |
U.S. Army Medical Research And Material Command |
Compositions and methods for treatment of filovirus-mediated diseases
|
|
US20120245213A1
(en)
|
2009-10-01 |
2012-09-27 |
Bedrich Mosinger |
Human type i taste receptor subunit 3 modulators and methods of using same
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
JP5847533B2
(ja)
|
2010-10-19 |
2016-01-27 |
田辺三菱製薬株式会社 |
新規甲状腺ホルモンβ受容体作動薬
|
|
WO2013006734A1
(en)
|
2011-07-05 |
2013-01-10 |
St. Jude Children's Research Hospital |
Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity
|
|
WO2013056232A2
(en)
|
2011-10-13 |
2013-04-18 |
Case Western Reserve University |
Rxr agonists compounds and methods
|
|
WO2014078892A1
(en)
|
2012-11-21 |
2014-05-30 |
Indyk Daniel |
A device and a test assembly for testing the integrity of a low voltage electrical network
|
|
WO2014178892A1
(en)
|
2013-05-03 |
2014-11-06 |
Scanlan Thomas S |
Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy
|
|
US9562012B2
(en)
|
2013-07-22 |
2017-02-07 |
Metabolic Solutions Development Company, Llc |
PPAR-sparing compounds for the treatment of metabolic diseases
|
|
US10258613B2
(en)
|
2014-02-05 |
2019-04-16 |
The Board Of Regents Of The University Of Oklahoma |
Compositions for treating retinal degeneration and methods of production and use thereof
|
|
WO2015188015A1
(en)
|
2014-06-04 |
2015-12-10 |
Haro Pharmaceutical Inc. |
18-20 member bi-polycyclic compounds
|
|
WO2016057322A1
(en)
|
2014-10-08 |
2016-04-14 |
Salk Institute For Biological Studies |
Ppar agonists and methods of use thereof
|
|
PE20180021A1
(es)
|
2015-02-20 |
2018-01-09 |
Univ Oregon Health & Science |
Derivados de sobetiroma
|
|
WO2017015360A1
(en)
|
2015-07-20 |
2017-01-26 |
Oregon Health & Science University |
Quinolone-3-diarylethers
|
|
US11872207B2
(en)
|
2015-12-24 |
2024-01-16 |
Mcmaster University |
Dronedarone and derivatives thereof for treating cancer
|
|
DK3457851T3
(da)
|
2016-05-18 |
2021-09-20 |
Univ Oregon Health & Science |
Derivater af sobetirom
|
|
US11325886B2
(en)
|
2016-08-12 |
2022-05-10 |
Oregon Health & Science University |
Amide compounds, pharmaceutical compositions thereof, and methods of using the same
|
|
WO2018208707A1
(en)
|
2017-05-08 |
2018-11-15 |
Neurovia, Inc. |
Methods and compositions for treating demyelinating diseases
|
|
US11578032B2
(en)
|
2018-02-14 |
2023-02-14 |
Oregon Health & Science University |
Derivatives of sobetirome
|
|
US11613517B2
(en)
|
2018-03-02 |
2023-03-28 |
Oregon Health & Science University |
Amide prodrugs of small molecule nuclear receptor modulators
|
|
WO2020117962A1
(en)
|
2018-12-05 |
2020-06-11 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis and inflammation
|
|
AU2019397067A1
(en)
|
2018-12-12 |
2021-07-22 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
WO2020118564A1
(en)
|
2018-12-12 |
2020-06-18 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
CN113474335B
(zh)
|
2019-02-21 |
2024-12-03 |
南京瑞捷医药科技有限公司 |
化合物及其作为甲状腺激素受体激动剂的用途
|
|
WO2020180624A1
(en)
|
2019-03-01 |
2020-09-10 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
KR20220017917A
(ko)
|
2019-05-08 |
2022-02-14 |
알리고스 테라퓨틱스 인코포레이티드 |
Thr-베타의 조절제 및 이의 사용 방법
|
|
US12466781B2
(en)
|
2019-11-29 |
2025-11-11 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|
|
MX2022008626A
(es)
*
|
2020-01-13 |
2022-08-22 |
Eccogene Shanghai Co Ltd |
Triazinonas sustituidas como agonistas del receptor de la hormona tiroidea.
|
|
US20230348364A1
(en)
|
2020-06-03 |
2023-11-02 |
Autobahn Therapeutics, Inc. |
Isotopic thyromimetic compounds
|
|
US20230242473A1
(en)
|
2020-06-17 |
2023-08-03 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|
|
WO2021257851A1
(en)
|
2020-06-17 |
2021-12-23 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|
|
US12590072B2
(en)
|
2020-06-17 |
2026-03-31 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|